ACTU Earnings

Quarterly EPS
$-0.55
Q3 2024
$-0.33
Q4 2024
$-0.32
Q1 2025
$-0.30
Q2 2025
$-0.25
Q3 2025
$-0.19
Q4 2025
$-0.24
Q1 2026
$-0.20
Q2 2026
Latest RevenueN/A
Latest Net Income-4866635
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.200-4866635+33.3%
Q1 2026-$0.240-5625749+25.0%
Q4 2025-$0.190-4553953+42.4%
Q3 2025-$0.250-5407470+54.5%
Q2 2025-$0.300-5949405-100.0%-236.4%
Q1 2025-$0.320-6317024
Q4 2024-$0.330-6446089
Q3 2024-$0.550-5970961
Q1 2011$0.2213.1M4.8M
Q4 2010
Actuate Therapeutics (ACTU) — Earnings